Cargando…
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Immunotherapies have shown benefits across a range of human cancers, but not pancreatic ductal adenocarcinoma (PDAC). Recent evidence suggests that the immunosuppressive tumor microenvironment (TME) constitutes an important roadblock to their efficacy. The landscape of the TME differs substantially...
Autores principales: | Falcomatà, Chiara, Bärthel, Stefanie, Schneider, Günter, Rad, Roland, Schmidt-Supprian, Marc, Saur, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900325/ https://www.ncbi.nlm.nih.gov/pubmed/36622087 http://dx.doi.org/10.1158/2159-8290.CD-22-0876 |
Ejemplares similares
-
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
por: Schneeweis, Christian, et al.
Publicado: (2022) -
Genetic Screens Identify a Context-Specific PI3K/p27(Kip1) Node Driving Extrahepatic Biliary Cancer
por: Falcomatà, Chiara, et al.
Publicado: (2021) -
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment
por: Falcomatà, Chiara, et al.
Publicado: (2022) -
Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation
por: Swietlik, Jonathan J., et al.
Publicado: (2023) -
Dual Recombinase–Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy
por: Sket, Tina, et al.
Publicado: (2023)